ProfileGDS4718 / 228425_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 90% 59% 76% 77% 68% 55% 89% 85% 63% 79% 77% 82% 85% 95% 91% 55% 82% 85% 64% 57% 73% 80% 71% 77% 74% 66% 58% 94% 84% 76% 88% 59% 88% 61% 90% 63% 90% 68% 87% 74% 76% 57% 62% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.2747990
GSM549102patient 115, normal, homogenized [OPG study]6.0830359
GSM549104patient 119, normal, homogenized [OPG study]7.466476
GSM549108patient 138, normal, homogenized [OPG study]7.4645477
GSM549119patient 077, normal, homogenized [OPG study]6.6988768
GSM549133patient 032, cancer, homogenized [OPG study]5.7836555
GSM549139patient 042, cancer, homogenized [OPG study]9.0931389
GSM549099patient 107, normal, homogenized [OPG study]8.463585
GSM549109patient 139, normal, homogenized [OPG study]6.3240663
GSM549110patient 046, normal, homogenized [OPG study]7.747279
GSM549114patient 063, normal, homogenized [OPG study]7.5658677
GSM549122patient 082, normal, homogenized [OPG study]8.120782
GSM549134patient 033, cancer, homogenized [OPG study]8.5308385
GSM549136patient 036, cancer, homogenized [OPG study]10.275195
GSM549140patient 044, cancer, homogenized [OPG study]9.3523791
GSM549111patient 047, normal, homogenized [OPG study]5.8034155
GSM549113patient 057, normal, homogenized [OPG study]8.2648882
GSM549132patient 031, cancer, homogenized [OPG study]8.4770385
GSM549137patient 038, cancer, homogenized [OPG study]6.3968964
GSM549142patient 047, cancer, homogenized [OPG study]6.0166557
GSM549100patient 110, normal, homogenized [OPG study]7.0733673
GSM549107patient 135, normal, homogenized [OPG study]7.8881480
GSM549115patient 068, normal, homogenized [OPG study]7.0066471
GSM549116patient 072, normal, homogenized [OPG study]7.6016677
GSM549120patient 078, normal, homogenized [OPG study]7.2113174
GSM549131patient 030, cancer, homogenized [OPG study]6.5383566
GSM549118patient 074, normal, homogenized [OPG study]5.971358
GSM549129patient 027, cancer, homogenized [OPG study]9.7982294
GSM549123patient 088, normal, homogenized [OPG study]8.3164284
GSM549124patient 006, cancer, homogenized [OPG study]7.3749776
GSM549126patient 015, cancer, homogenized [OPG study]8.8037688
GSM549128patient 025, cancer, homogenized [OPG study]6.0962759
GSM549103patient 117, normal, homogenized [OPG study]8.7289488
GSM549117patient 073, normal, homogenized [OPG study]6.1103761
GSM549138patient 041, cancer, homogenized [OPG study]9.2143990
GSM549141patient 045, cancer, homogenized [OPG study]6.3721263
GSM549130patient 028, cancer, homogenized [OPG study]9.1416590
GSM549101patient 111, normal, homogenized [OPG study]6.6933168
GSM549105patient 128, normal, homogenized [OPG study]8.6351587
GSM549106patient 134, normal, homogenized [OPG study]7.3622774
GSM549112patient 048, normal, homogenized [OPG study]7.4466876
GSM549125patient 011, cancer, homogenized [OPG study]5.9372457
GSM549127patient 024, cancer, homogenized [OPG study]6.3210262
GSM549135patient 035, cancer, homogenized [OPG study]9.9820494